LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Colayco, Sharon A"
  2. AU="Shangase, Sindisiwe Londiwe"
  3. AU="Yang, Fuman"
  4. AU="Kaur, Divjot"

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Allosteric Inhibition of Ubiquitin-like Modifications by a Class of Inhibitor of SUMO-Activating Enzyme.

Li, Yi-Jia / Du, Li / Wang, Jianghai / Vega, Ramir / Lee, Terry D / Miao, Yunan / Aldana-Masangkay, Grace / Samuels, Eric R / Li, Baozong / Ouyang, S Xiaohu / Colayco, Sharon A / Bobkova, Ekaterina V / Divlianska, Daniela B / Sergienko, Eduard / Chung, Thomas D Y / Fakih, Marwan / Chen, Yuan

Cell chemical biology

2018  Volume 26, Issue 2, Page(s) 278–288.e6

Abstract: Ubiquitin-like (Ubl) post-translational modifications are potential targets for therapeutics. However, the only known mechanism for inhibiting a Ubl-activating enzyme is through targeting its ATP-binding site. Here we identify an allosteric inhibitory ... ...

Abstract Ubiquitin-like (Ubl) post-translational modifications are potential targets for therapeutics. However, the only known mechanism for inhibiting a Ubl-activating enzyme is through targeting its ATP-binding site. Here we identify an allosteric inhibitory site in the small ubiquitin-like modifier (SUMO)-activating enzyme (E1). This site was unexpected because both it and analogous sites are deeply buried in all previously solved structures of E1s of ubiquitin-like modifiers (Ubl). The inhibitor not only suppresses SUMO E1 activity, but also enhances its degradation in vivo, presumably due to a conformational change induced by the compound. In addition, the lead compound increased the expression of miR-34b and reduced c-Myc levels in lymphoma and colorectal cancer cell lines and a colorectal cancer xenograft mouse model. Identification of this first-in-class inhibitor of SUMO E1 is a major advance in modulating Ubl modifications for therapeutic aims.
MeSH term(s) Allosteric Regulation ; Allosteric Site ; Animals ; Cell Line, Tumor ; High-Throughput Screening Assays ; Humans ; Mice ; Mice, SCID ; MicroRNAs/metabolism ; Proto-Oncogene Proteins c-myc/genetics ; Proto-Oncogene Proteins c-myc/metabolism ; Small Molecule Libraries/chemistry ; Small Molecule Libraries/pharmacology ; Sumoylation/drug effects ; Transplantation, Heterologous ; Ubiquitin/metabolism ; Ubiquitin-Activating Enzymes/antagonists & inhibitors ; Ubiquitin-Activating Enzymes/metabolism ; Ubiquitination/drug effects
Chemical Substances MIRN34 microRNA, human ; MicroRNAs ; Proto-Oncogene Proteins c-myc ; Small Molecule Libraries ; Ubiquitin ; Ubiquitin-Activating Enzymes (EC 6.2.1.45)
Language English
Publishing date 2018-12-20
Publishing country United States
Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
ISSN 2451-9448
ISSN (online) 2451-9448
DOI 10.1016/j.chembiol.2018.10.026
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top